Cancer cells are hard to get rid of because they continually find ways to evade treatment and survive. That's what a new study in Cancer Cell makes clear, says Tim Barribeau at the IO9 blog. The researchers studied anti-angiogenic therapies, which shrink tumors by going after pericytes — the cells that help tumors make blood vessels to feed themselves.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.